Assaying the Stability and Inactivation of AAV Serotype 1 Vectors

Human gene therapy methods - United States
doi 10.1089/hgtb.2016.180
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Mary Ann Liebert Inc

Related search

Production and Characterization of Vectors Based on the Cardiotropic AAV Serotype 9

Methods in Molecular Biology
GeneticsMolecular Biology
2016English

404. Systematical Evaluation of Tropism of Different AAV Serotype Vectors in Adult and Neonatal Mice Following I.V. Injections

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2011English

Novel Random Peptide Libraries Displayed on AAV Serotype 9 for Selection of Endothelial Cell-Directed Gene Transfer Vectors

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2011English

AAVR: A Multi-Serotype Receptor for AAV

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2016English

681. rDNA-AAV Vectors for the Treatment of Phenylketonuria

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2010English

Nanobody-Enhanced Targeting of AAV Gene Therapy Vectors

Molecular Therapy - Methods and Clinical Development
Molecular MedicineGeneticsMolecular Biology
2019English

AAV Serotype-1 Mediates Early Onset of Gene Expression in Mouse Hearts and Results in Better Therapeutic Effect

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2006English

GluA4-targeted AAV Vectors Deliver Genes Selectively to Interneurons While Relying on the AAV Receptor for Entry

Molecular Therapy - Methods and Clinical Development
Molecular MedicineGeneticsMolecular Biology
2019English

Serotype-Independent Method of Recombinant Adeno-Associated Virus (AAV) Vector Production and Purification

Journal of Nippon Medical School
Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy